1. ALLA AKTIER
  2. NYHETER
  3. BRAINCOOL

BrainCool

Nyheter BrainCool Nyheter alla bolag

Correction: BrainCool AB (publ) - Year End Report 2023

MAR

Correction addresses the number of delivered system for quarter four.

Jon Berg, CEO Comments
“Unfortunately, BrainCool has published an incorrect number of delivered systems in the CEO comments for quarter four. This has no impact on the financial statements.
 
The correct comment should be:
We succeeded in delivering around 25 systems in December and in total 37 systems for quarter four. For the year as whole, we delivered over 70 systems.
 
We are very sorry for the mistake.”

Contact
For more information
Jon Berg - CEO
+46 722 50 91 19
e-mail: jon.berg@braincool.se

About Us
BrainCool AB (publ) is an innovative medical device company that develops, markets, and sells leading medical cooling systems for indications and areas with significant medical benefits within the healthcare sector. BrainCool AB (publ) is based in Lund, Sweden, and its share is listed on Nasdaq First North Growth Market, named “BRAIN”.
Eminova Fondkommission AB is the company’s Certified Adviser.

This information is information that BrainCool is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact persons set out above, at 2024-02-29 17:45 CET.

Attachments
Year End Report Q4 2023 Correction

Datum 2024-02-29, kl 17:45
Källa MFN
Bifogade filer
Year End Report Q4 2023 Correction
Affiliate
Kom igång med ditt sparande på bara några minuter! Hos Avanza handlar du aktier från 0 kr på Stockholmsbörsen och får tillbaka alla fondavgifter (ja, alla!) upp till 50 000 kr i samlat sparande. Kanske är det därför Avanza har Sveriges nöjdaste sparare 15 år i rad.
Investeringar innebär en risk